| Entry |
|
|---|
| Name |
Clidinium bromide (USP/INN);
Quarzan (TN) |
|---|
| Formula |
C22H26NO3. Br
|
|---|
| Exact mass |
431.1096
|
|---|
| Mol weight |
432.3507
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
|
|---|
| Remark |
| Product (mixture): | D10247<US> |
|
|---|
| Efficacy |
Muscarinic acetylcholine receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
D00716 Clidinium bromide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D00716 Clidinium bromide (USP/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 27
1 X Br 29.2971 -15.9198 #-
2 C1d C 26.8587 -18.5281
3 C8y C 28.0885 -19.2306
4 C8y C 26.8571 -17.1168
5 C7a C 25.6466 -19.2410
6 C8x C 29.3085 -18.5199
7 C8x C 28.0901 -20.6417
8 C8x C 28.0800 -16.4111
9 C8x C 25.6302 -16.4192
10 O7a O 24.4318 -18.5296
11 O6a O 25.6534 -20.6492
12 C8x C 30.5304 -19.2202
13 C8x C 29.3170 -21.3395
14 C8x C 28.0704 -14.9976
15 C8x C 25.6286 -15.0079
16 C1y C 23.2226 -19.2475
17 C8x C 30.5371 -20.6286
18 C8x C 26.8486 -14.2972
19 C1y C 21.9624 -18.5156
20 C1x C 23.2139 -20.6984
21 C1x C 20.7012 -19.2368
22 C1x C 22.3748 -19.8356
23 N2y N 21.9578 -21.4169 #+
24 C1x C 20.7025 -20.6819
25 C1x C 21.5304 -20.0249
26 O1a O 28.0711 -17.8281
27 C1a C 21.9578 -22.8169
BOND 29
1 2 3 1
2 2 4 1
3 2 5 1
4 3 6 1
5 3 7 2
6 4 8 2
7 4 9 1
8 5 10 1
9 5 11 2
10 6 12 2
11 7 13 1
12 8 14 1
13 9 15 2
14 10 16 1
15 12 17 1
16 14 18 2
17 16 19 1
18 16 20 1
19 19 21 1
20 19 22 1
21 20 23 1
22 21 24 1
23 22 25 1
24 13 17 2
25 15 18 1
26 23 24 1
27 23 25 1
28 2 26 1
29 23 27 1
|
|---|
